Clinical Trial

Spatial Transcriptomics in Kidney Transplantation

Study acronym: SPACE-KiT
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The study is an investigator-led, prospective, longitudinal, observational cohort study. The central hypothesis for this study is that spatial data will reveal new insights to immune cell function and local interactions within the kidney tissue to better predict important clinical outcomes. Investigators aspire to establish a prospective, longitudinal cohort to improve the diagnosis and management of kidney transplant rejection using precision pathology. By utilising new spatial technologies, the investigators aim to: * Derive a spatially resolved transcriptomic signature of kidney transplant rejection subtypes * Derive accurate transcriptomic signatures aligned with key cell types within the transplant kidney * Develop refinements to histological kidney rejection diagnostic and scoring classification * Correlate of spatial and refined biopsy scoring features to clinically important outcomes
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-02-24; most recent amendment 2024-04-22.
Status change: Not Yet Recruiting → Enrolling by Invitation 2024-04-22
Trial Details
NCT Number NCT06288425
Lead Sponsor Western Sydney Local Health District
Conditions Transplant Complication, Kidney Injury
Enrollment 500 participants
Start Date 2024-04-03
Primary Completion 2030-01-01 (estimated)
Study Completion 2035-01-01 (estimated)
Updated on ClinicalTrials.gov 2024-04-24